These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 124237)

  • 41. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM; Kiselova ES
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro acetylation of drugs by human blood cells.
    Drayer DE; Strong JM; Jones B; Sandler A; Reidenberg MM
    Drug Metab Dispos; 1974; 2(6):499-505. PubMed ID: 4155674
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 44. The influence of D-glucose and p-aminosalicylic acid on the metabolism of isoniazid.
    Peters JH; Gill M; Hayes VE
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):340-52. PubMed ID: 5916739
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bacteriostatic activity of the blood in tuberculosis].
    Zhoglo SI
    Probl Tuberk; 1970; 48(8):61-3. PubMed ID: 5496742
    [No Abstract]   [Full Text] [Related]  

  • 46. [Histochemical study of alkaline and acid phosphatase in prolonged therapy of tuberculosis].
    Zemskova ZS; Lesnaia AA
    Probl Tuberk; 1967; 45(4):74-7. PubMed ID: 5629121
    [No Abstract]   [Full Text] [Related]  

  • 47. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

  • 48. [Chemotherapeutic properties of the alkaloid tetrandrin in experimental tuberculosis].
    Vichkanova SA; Makarova LV; Solov'eva LF
    Farmakol Toksikol; 1973; 36(1):74-8. PubMed ID: 4734361
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparison of the level of free isonicotinic acid hydrazine in the blood serum determined with a vertical method after the oral administration of INH alone, INH with PAS or Napashin].
    KOLOSOWSKA J; LIBISZOWSKA-STANIUL M
    Gruzlica (1926); 1962 Jan; 30():35-8. PubMed ID: 14458075
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetics of isoniazid metabolism in man.
    Ellard GA; Gammon PT
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):83-113. PubMed ID: 950592
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

  • 52. [The importance of estimating the individual acetylation rate in modern tuberculosis treatment].
    Duru S
    Mikrobiyol Bul; 1979 Jan; 13(1):53-61. PubMed ID: 555792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoniazid dosage in patients with renal failure.
    Bowersox DW; Wintebauer RH; Stewart GL; Orme B; Barron E
    N Engl J Med; 1973 Jul; 289(2):84-7. PubMed ID: 4710409
    [No Abstract]   [Full Text] [Related]  

  • 54. [The efficacy of treatment of diffuse infiltrative-pneumonic pulmonary tuberculosis].
    Pervova TN; Polevikt GK
    Probl Tuberk; 1966; 44(4):10-5. PubMed ID: 6011830
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chemotherapy research on tuberculosis in various countries].
    Kekkaku; 1985 May; 60(5):287-92. PubMed ID: 3897687
    [No Abstract]   [Full Text] [Related]  

  • 56. [Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
    Albengres E; Houin G; Breau JL; Hirsch A; Saltiel JC; Tillement JP; Chrétien J
    Nouv Presse Med; 1977 Oct; 6(32):2869-71. PubMed ID: 917803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of antacids on gastrointestinal absorption of isoniazid in rat and man.
    Hurwitz A; Schlozman DL
    Am Rev Respir Dis; 1974 Jan; 109(1):41-7. PubMed ID: 4588090
    [No Abstract]   [Full Text] [Related]  

  • 58. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
    Wagner J; Dolezal V
    Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
    [No Abstract]   [Full Text] [Related]  

  • 59. [Possibilities of curing tuberculosis in patients with silicotuberculosis].
    Pichugin VA
    Gig Tr Prof Zabol; 1974 Apr; 18(4):48-9. PubMed ID: 4858588
    [No Abstract]   [Full Text] [Related]  

  • 60. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
    Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P
    Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.